Biosysen Proposes Share Capital Increase
Biosysen (HKG:1355) is proposing to increase its authorized share capital to HK$100 million divided into 10 billion shares, subject to shareholder approval.The company will do this by creating an additional 8 billion shares, according to a Wednesday Hong Kong bourse filing.The move comes to accommodate the potential growth of the company and give it greater flexibility to raise funds in the future.The company currently has 1.19 billion shares in issue and 806.9 million authorized but unissued.